Audiological Devices Market

Audiological Devices Market Forecast Analysis, By Product (ITE, RITE, BTE, CHA, Cochlear Implants, Others), By Disease Type (Otosclerosis, Acoustic Tumors, Otitis Media, Others), By End-User (Hospitals, Ambulatory Surgical Centers, Clinics), & Region - Global Market insights 2022-2032

Analysis of Audiological Devices Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Audiological Devices Market Outlook (2022-2032)

The Audiological Devices market reached a valuation of US$ 10.27 Billion by 2021, and is likely to register a Y-o-Y growth rate of 4.0% in 2022, closing at US$ 10.81 Billion. Furthermore, across the 2022-2032 period of assessment, growth is expected to accelerate at a whopping 5.3% CAGR, reaching US$ 18.13 Billion.

According to Fact.MR, adoption of audiological devices is rising, attributed to the increasing prevalence of hearing loss. Cases of Hearing loss are rising constantly, owing to the exposure of loud noise in the environment. As per the World Health Organization (WHO), around 466 million people suffer from some form of hearing loss on the global aspect, and this number is expected to touch 900 million by the year 2050.

With the increase in awareness about hearing loss and its implications, people have inclined towards seeking timely diagnosis and treatment. This is one of the major factors driving the growth of the audiological devices market over the forecast period. Also, technological advancements have resulted in the development of sophisticated and user-friendly devices, which is further expected to boost the growth of the audiological devices market.

Report Attributes

Details

Anticipated Base Year Value (2021)

US$ 10.27 Billion

Expected Market Value (2022)

US$ 10.81 Billion

Projected Forecast Value (2032)

US$ 18.13 Billion

Global Growth Rate (2022-2032)

5.3% CAGR

Expected Growth Rate of North America (2022-2032)

5.2% CAGR

Anticipated Growth Rate of Asia Pacific (2022-2032)

5.1% CAGR

Prominent Audiological Devices Service Players

  • William Demant Holding A/S
  • GN Store Nord A/S
  • Sonova
  • WIDEX A/S
  • Sivantos Pte. Ltd.

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

2017-2021 Revenue Analysis of Audiological Devices Market vs. Growth Outlook 2022-2032

According to Fact.MR’s report, Audiological Devices demand exhibited a CAGR of over 2.4% from 2017 to 2021.

The competitive surgical procedure costs (including the ENT procedures, involving the implantation of cochlear implants) offered by prominent healthcare facilities are a key factor driving the medical tourism sector in developing countries.

For instance, healthcare treatment costs up to 65-80% less in Malaysia as compared to the US. In 2019, Malaysia and India were the most popular destinations for medical tourism in the world.

Thus, the growth in the medical tourism sector, coupled with the rising healthcare expenditure and improving healthcare infrastructure, is expected to drive the demand for hearing aids across emerging markets during the forecast period.

Key Market Drivers Influencing Audiological Devices Industry Expansion

Emerging Markets to Escalate the Market Growth

An increase in demand for hearing products, cochlear devices, and diagnostic devices in ENT and other clinics is expected to drive the growth of the audiological devices market in the near future. Hearing care clinics provide audiology services that involves hearing and balance assessment. Moreover, the increasing demand of the market is attributed to the increasing demand for quality care services.

Technological advancements and product innovation leading to development making audiological devices increasingly smaller in size and more efficient, coupled with low cost of device are the major factors that are anticipated to augment the growth of audiological devices market during the forecast period. Hearing aids dominate the audiology devices market as they provide enhanced connectivity, enhanced user friendliness and possess superior comfort.

Increasing Incidences of Hearing Loss to Propel Market Growth Prospects

According to the Hearing Loss Association of America (HLAA), hearing loss is considered to be the third most common physical condition after arthritis and heart disease, which has been affecting people of all ages. Gradual hearing loss can affect people of all ages, differing from mild to profound. It can be mild or severe, temporary or permanent, depending on the cause.

Similarly, according to the WHO, a person who is unable to hear as well as someone with normal hearing thresholds of 25 dB or better in both ears is considered to have hearing loss. An increase in the prevalence is estimated to drive the requirement for diagnosis and treatment, which, in turn, is expected to escalate the growth of the audiological devices market over the analysis period.

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

Key Challenges encountered by Audiological Devices Industry

High Cost of Devices as well as the Surgeries to Hinder the Market Growth

High cost and the social stigma associated with the appearance of these devices are the major factors that are expected to impede the growth of the Audiological Devices Market during the forecast period.

Additionally, the high prices hearing impairment solutions, particularly those based on surgery, are also expected to pose a challenge to the audiology devices market throughout the analysis period.

Concerns Regarding Aesthetic Appeal to Hamper the Market Growth

Hearing aids and cochlear implants can significantly improve accessibility and quality of life for people with aural impairments, but for some users, sociocultural issues and perceived stigma may leave them unwilling to wear the devices. Many individuals choose to abandon the hearing aids or implants. This is one of the major factors that is anticipated to limit the market growth in the forthcoming years.

Additionally, the stigma associated with deafness, coupled with frequent maintenance and implant surgeries are also projected to stymie market expansion over the analysis period.

Region-wise Analysis

How will North America Perform in the Global Audiological Devices Industry Landscape?

Rise in the Hearing Impairment Cases to Boost the Market Growth in North America

The North American Audiological Devices Market will grow at a CAGR of 5.2% from 2022 to 2032.

The market in North America represents the largest market share of 39.32% in 2022. Further, the market in the expected to remain the dominant region over the forecast period, owing to the higher prevalence of hearing impairment in the region. According to one of the estimates, 1 in 20 Americans are currently deaf or hard of hearing and there are roughly 10 million people who have hearing loss, and there are about 1 million people who are functionally deaf.

Hearing aid employment has been associated with decreases in the incidence or severity of depression, cognitive decline, and other health issues in older persons, among other health advantages. Furthermore, the usage of hearing aids can lead to increased social involvement and higher life quality.

How will the Growth of Audiological Devices Market Escalate across Asia Pacific?

Rise in the Geriatric Population to Enhance the Market Prospects

The Audiological Devices Market in Asia Pacific is expected to grow at a CAGR of 5.1% from 2022 to 2032.

The market in Asia Pacific region is estimated to gain a significant market share over the analysis period, attributed to the growing geriatric population, backed by the rising prevalence of hearing impairment among the aged population in the region. It is believed that by 2050, one in four people in the Asia Pacific region is estimated to be older than 60. Moreover, the doubling disposable income and increasing cost of treating these impairments in the region are anticipated to boost the regional market growth in the near future.

Furthermore, Asian countries, such as India and China have a large geriatric population, thereby rendering lucrative growth. Also, constantly improving healthcare infrastructure, increasing product awareness, and rising health care expenditures are some other factors that are expected to accelerate the growth of the regional market.

Region-wise Forecast CAGRs for the Audiological Devices Market

Region CAGR

North America

5.2%

Asia Pacific

5.1%

Europe

5.0%

Latin America

5.1%

Middle East & Africa

5.0%

Category-wise Insights

Which Segment to Remain Dominant in the Product Category?

Hearing Aids Segment to Enhance Growth Prospects

According to Fact.MR’s data, preference for Hearing Aids segment is expected to expand at a CAGR of 5.2% over the forecast period.  

The segment accounted for the maximum share of more than 64.00% of the overall revenue in 2021, attributed to the demand for complete-in-canal hearing aids, and invisible-in-canal hearing aids.

As per the article published in June 2022 titled ‘Prevalence of Hearing Impairment by Age in the United States in National Library of Medicine, twenty-five percent of men in their late 50s had some level of hearing impairment, 50% in their late 60s, and 75% in their late 70s. For women, 25% had some level of Hearing Impairment in their early 60s, 50% in their early 70s, and 75% in their late 70s.

In addition, factors such as the launch of new products, a continuous collaboration by major players, rising awareness about hearing impairment, and market expansion are propelling the growth of the segment. For instance, In February 2022, Phonak announced the launch of the Virto line of custom-made hearing aids which includes the Virto P Black, in-the-ear (ITE) hearing device, and the super-discreet Virto P-Titanium.

Which is the Most Sought-after Disease Type Category?

Meniere’s Disease to Boost the Segment’s Growth

According to Fact.MR’s data, preference for Meniere’s Disease segment is expected to expand at a CAGR of 5.1% over the forecast period.

The segment is expected to grow at a significant pace during the forecast period. Meniere's disease is a disorder of the inner ear that causes, ringing in the ears (tinnitus), severe dizziness (vertigo), hearing loss, and a feeling of fullness or congestion in the ear.

According to American Hearing Research Foundation, in the U.S., approximately, 0.2% of the population suffers from Meniere’s disease, and every year about 45,500 new cases are diagnosed.

Meniere's disease usually affects only one ear. Attacks of dizziness may take place suddenly or after a short period of tinnitus or muffled hearing. Some people with Meniere’s disease have vertigo so extreme that they lose their balance and fall. These episodes are called drop attacks.

Don't Need a Global Report?

save 40%! on Country & Region specific reports

Audiological Devices Market- Competitive Landscape

Prominent players in the Audiological Devices Industry are taking advantage of the rapidly increasing demand for the Audiological Devices in various applications. To further their outreach, players are relying on collaborations, partnerships and acquisitions with existing small, medium and large-scale vendors. Some prominent market developments are as follows :

  • In August 2022, GN declared to introduce the Jabra Enhance Plus, a little true wireless earbud that offers a 3-in-1 experience of calls, music, and hearing enhancement.
  • In April 2022, for its brand, Signia, WS Audiology A/S received an iF Design award. For the third time, Signia received the prize owing to their Insio Charge & Go AX hearing aids. It is renowned for its comfort and discrete shape, contactless charging, and direct streaming from Android and iOS.
  • In February 2021, Cochlear Limited announced it is partnering with leading hearing health experts to conduct the largest ever international clinical study of an investigational cochlear implant that releases a glucocorticoid (anti-inflammatory) drug therapy directly to the cochlea. The CI-DEX Study is a pivotal, prospective, multi-centre, randomised, blinded study evaluating the effect of a glucocorticoid releasing cochlear implant in up to 120 adults in Australia and the United States with moderate to profound sensorineural hearing loss.

Key Segments Covered in the Audiological Devices Industry Survey

  • By Product :

    • Hearing Aids
    • In-the-ear Hearing Aids (ITE)
    • Receiver-in-the-ear Hearing Aids (RITE)
    • Behind-the-ear Hearing Aids (BTE)
    • Canal Hearing Aids (CHA)
    • Cochlear Implants
    • Bone-anchored Healing Aids
    • Diagnostic Devices:
      • Audiometers
      • Octoscopes
      • Tympanometers
  • By Disease Type :

    • Otosclerosis
    • Meniere’s Disease
    • Acoustic Tumors
    • Otitis Media
    • Others
  • By End-User :

    • Hospitals
    • Ambulatory Surgical Centers
    • Clinics
  • By Region :

    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

Table of Content

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

5. Market Outlook

    5.1. Key Mergers & Acquisitions

    5.2. Technological Advancements

    5.3. Regulatory Scenario of Audiological Devices

6. Global Market Analysis and Forecast, by Product

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Global Market Value Forecast, by Product, 2022–2032

        6.3.1. Hearing Aids

            6.3.1.1. In-the-ear Hearing Aids (ITE)

            6.3.1.2. Receiver-in-the-ear hearing Aids (RITE)

            6.3.1.3. Behind-the-ear Hearing Aids (BTE)

            6.3.1.4. Canal hearing aids (CHA)

        6.3.2. Cochlear Implants

        6.3.3. Bone-anchored Hearing Aids

        6.3.4. Diagnostic Devices

            6.3.4.1. Audiometers

            6.3.4.2. Octoscopes

            6.3.4.3. Tympanometers

    6.4. Global Market Attractiveness, by Product

7. Global Market Analysis and Forecast, by Disease

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Global Market Value Forecast, by Disease, 2022–2032

        7.3.1. Otosclerosis

        7.3.2. Meniere's Disease

        7.3.3. Acoustic Tumors

        7.3.4. Otitis Media

        7.3.5. Others

    7.4. Global Market Attractiveness, by Disease

8. Global Market Analysis and Forecast, by End-user

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Global Market Value Forecast, by End-user, 2022–2032

        8.3.1. Hospitals

        8.3.2. Ambulatory Surgical Centers

        8.3.3. Clinics

    8.4. Global Market Attractiveness, by End-user

9. Global Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Global Market Value Forecast, by Region

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Global Market Attractiveness, by Country/Region

10. North America Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. North America Market Value Forecast, by Product, 2022–2032

        10.2.1. Hearing Aids

            10.2.1.1. In-the-ear Hearing Aids (ITE)

            10.2.1.2. Receiver-in-the-ear hearing Aids (RITE)

            10.2.1.3. Behind-the-ear Hearing Aids (BTE)

            10.2.1.4. Canal hearing aids (CHA)

        10.2.2. Cochlear Implants

        10.2.3. Bone-anchored Hearing Aids

        10.2.4. Diagnostic Devices

            10.2.4.1. Audiometers

            10.2.4.2. Octoscopes

            10.2.4.3. Tympanometers

    10.3. North America Market Value Forecast, by Disease, 2022–2032

        10.3.1. Otosclerosis

        10.3.2. Meniere's Disease

        10.3.3. Acoustic Tumors

        10.3.4. Otitis Media

        10.3.5. Others

    10.4. North America Market Value Forecast, by End-user, 2022–2032

        10.4.1. Hospitals

        10.4.2. Ambulatory Surgical Centers

        10.4.3. Clinics

    10.5. North America Market Value Forecast, by Country, 2022–2032

        10.5.1. U.S.

        10.5.2. Canada

    10.6. North America Market Attractiveness Analysis

        10.6.1. By Product

        10.6.2. By Disease

        10.6.3. By End-user

        10.6.4. By Country

11. Europe Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Europe Market Value Forecast, by Product, 2022–2032

        11.2.1. Hearing Aids

            11.2.1.1. In-the-ear Hearing Aids (ITE)

            11.2.1.2. Receiver-in-the-ear hearing Aids (RITE)

            11.2.1.3. Behind-the-ear Hearing Aids (BTE)

            11.2.1.4. Canal hearing aids (CHA)

        11.2.2. Cochlear Implants

        11.2.3. Bone-anchored Hearing Aids

        11.2.4. Diagnostic Devices

            11.2.4.1. Audiometers

            11.2.4.2. Octoscopes

            11.2.4.3. Tympanometers

    11.3. Europe Market Value Forecast, by Disease, 2022–2032

        11.3.1. Otosclerosis

        11.3.2. Meniere's Disease

        11.3.3. Acoustic Tumors

        11.3.4. Otitis Media

        11.3.5. Others

    11.4. Europe Market Value Forecast, by End-user, 2022–2032

        11.4.1. Hospitals

        11.4.2. Ambulatory Surgical Centers

        11.4.3. Clinics

    11.5. Europe Market Value Forecast, by Country/Sub-region, 2022–2032

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Russia

        11.5.7. Rest of Europe

    11.6. Europe Market Attractiveness Analysis

        11.6.1. By Product

        11.6.2. By Disease

        11.6.3. By End-user

        11.6.4. By Country/Sub-region

12. Asia Pacific Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Europe Market Value Forecast, by Product, 2022–2032

        12.2.1. Hearing Aids

            12.2.1.1. In-the-ear Hearing Aids (ITE)

            12.2.1.2. Receiver-in-the-ear hearing Aids (RITE)

            12.2.1.3. Behind-the-ear Hearing Aids (BTE)

            12.2.1.4. Canal hearing aids (CHA)

        12.2.2. Cochlear Implants

        12.2.3. Bone-anchored Hearing Aids

        12.2.4. Diagnostic Devices

            12.2.4.1. Audiometers

            12.2.4.2. Octoscopes

            12.2.4.3. Tympanometers

    12.3. Europe Market Value Forecast, by Disease, 2022–2032

        12.3.1. Otosclerosis

        12.3.2. Meniere's Disease

        12.3.3. Acoustic Tumors

        12.3.4. Otitis Media

        12.3.5. Others

    12.4. Europe Market Value Forecast, by End-user, 2022–2032

        12.4.1. Hospitals

        12.4.2. Ambulatory Surgical Centers

        12.4.3. Clinics

    12.5. Europe Market Value Forecast, by Country/Sub-region, 2022–2032

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Europe Market Attractiveness Analysis

        12.6.1. By Product

        12.6.2. By Disease

        12.6.3. By End-user

        12.6.4. By Country/Sub-region

13. Latin America Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Latin America Market Value Forecast, by Product, 2022–2032

        13.2.1. Hearing Aids

            13.2.1.1. In-the-ear Hearing Aids (ITE)

            13.2.1.2. Receiver-in-the-ear hearing Aids (RITE)

            13.2.1.3. Behind-the-ear Hearing Aids (BTE)

            13.2.1.4. Canal hearing aids (CHA)

        13.2.2. Cochlear Implants

        13.2.3. Bone-anchored Hearing Aids

        13.2.4. Diagnostic Devices

            13.2.4.1. Audiometers

            13.2.4.2. Octoscopes

            13.2.4.3. Tympanometers

    13.3. Market Value Forecast, by Disease, 2022–2032

        13.3.1. Otosclerosis

        13.3.2. Meniere's Disease

        13.3.3. Acoustic Tumors

        13.3.4. Otitis Media

        13.3.5. Others

    13.4. Latin America Market Value Forecast, by End-user, 2022–2032

        13.4.1. Hospitals

        13.4.2. Ambulatory Surgical Centers

        13.4.3. Clinics

    13.5. Latin America Market Value Forecast, by Country, 2022–2032

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Latin America Market Attractiveness Analysis

        13.6.1. By Product

        13.6.2. By Disease

        13.6.3. By End-user

        13.6.4. By Country/Sub-region

14. Middle East & Africa Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Middle East & Africa Market Value Forecast, by Product, 2022–2032

        14.2.1. Hearing Aids

            14.2.1.1. In-the-ear Hearing Aids (ITE)

            14.2.1.2. Receiver-in-the-ear hearing Aids (RITE)

            14.2.1.3. Behind-the-ear Hearing Aids (BTE)

            14.2.1.4. Canal hearing aids (CHA)

        14.2.2. Cochlear Implants

        14.2.3. Bone-anchored Hearing Aids

        14.2.4. Diagnostic Devices

            14.2.4.1. Audiometers

            14.2.4.2. Octoscopes

            14.2.4.3. Tympanometers

    14.3. Middle East & Africa Market Value Forecast, by Disease, 2022–2032

        14.3.1. Otosclerosis

        14.3.2. Meniere's Disease

        14.3.3. Acoustic Tumors

        14.3.4. Otitis Media

        14.3.5. Others

    14.4. Middle East & Africa Market Value Forecast, by End-user, 2022–2032

        14.4.1. Hospitals

        14.4.2. Ambulatory Surgical Centers

        14.4.3. Clinics

    14.5. Middle East & Africa Market Value Forecast, by Country/Sub-region, 2022–2032

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Israel

        14.5.4. Rest of Middle East & Africa

    14.6. Middle East & Africa Market Attractiveness Analysis

        14.6.1. By Product

        14.6.2. By Disease

        14.6.3. By End-user

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Company Profiles

        15.1.1. William Demant Holding A/S

            15.1.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.1.1.2. Company Financials

            15.1.1.3. Growth Strategies

            15.1.1.4. SWOT Analysis

        15.1.2. GN Store Nord A/S

            15.1.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.1.2.2. Company Financials

            15.1.2.3. Growth Strategies

            15.1.2.4. SWOT Analysis

        15.1.3. Sonova

            15.1.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.1.3.2. Company Financials

            15.1.3.3. Growth Strategies

            15.1.3.4. SWOT Analysis

        15.1.4. WIDEX A/S

            15.1.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.1.4.2. Company Financials

            15.1.4.3. Growth Strategies

            15.1.4.4. SWOT Analysis

        15.1.5. Sivantos Pte. Ltd.

            15.1.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.1.5.2. Company Financials

            15.1.5.3. Growth Strategies

            15.1.5.4. SWOT Analysis

        15.1.6. Medtronic

            15.1.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.1.6.2. Company Financials

            15.1.6.3. Growth Strategies

            15.1.6.4. SWOT Analysis

        15.1.7. Starkey

            15.1.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.1.7.2. Company Financials

            15.1.7.3. Growth Strategies

            15.1.7.4. SWOT Analysis

        15.1.8. Audina Hearing Instruments, Inc.

            15.1.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.1.8.2. Company Financials

            15.1.8.3. Growth Strategies

            15.1.8.4. SWOT Analysis

        15.1.9. AUDITDATA

            15.1.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.1.9.2. Company Financials

            15.1.9.3. Growth Strategies

            15.1.9.4. SWOT Analysis

        15.1.10. Nurotron Biotechnology Co. Ltd.

            15.1.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.1.10.2. Company Financials

            15.1.10.3. Growth Strategies

            15.1.10.4. SWOT Analysis

Don't Need a Global Report?

save 40%! on Country & Region specific reports

List Of Table

Table 01: Global Market Value (US$ Mn) Forecast, by Product, 2022–2032

Table 02: Global Market Value (US$ Mn) Forecast, by Hearing Aids, 2022–2032

Table 03: Global Market Value (US$ Mn) Forecast, by Diagnostic Devices, 2022-2032

Table 04: Global Market Value (US$ Mn) Forecast, by Disease, 2022–2032

Table 05: Global Market Value (US$ Mn) Forecast, by End-user, 2022–2032

Table 06: Global Value (US$ Mn) Forecast, by Region, 2022–2032

Table 07: North America Market Value (US$ Mn) Forecast, by Country, 2022–2032

Table 08: North America Market Value (US$ Mn) Forecast, by Product, 2022–2032

Table 09: North America Market Value (US$ Mn) Forecast, by Hearing Aids, 2022–2032

Table 10: North America Market Value (US$ Mn) Forecast, by Diagnostic Devices, 2022–2032

Table 11: North America Market Value (US$ Mn) Forecast, by Disease, 2022–2032

Table 12: North America Market Value (US$ Mn) Forecast, by End-user, 2022–2032

Table 13: Europe Market Value (US$ Mn) Forecast, by Country/Sub-region, 2022–2032

Table 14: Europe Market Value (US$ Mn) Forecast, by Product, 2022–2032

Table 15: Europe Market Value (US$ Mn) Forecast, by Hearing Aids, 2022–2032

Table 16: Europe Market Value (US$ Mn) Forecast, by Diagnostic Devices, 2022–2032

Table 17: Europe Market Value (US$ Mn) Forecast, by Disease, 2022–2032

Table 18: Europe Market Value (US$ Mn) Forecast, by End-user, 2022–2032

Table 19: Asia Pacific Market Value (US$ Mn) Forecast, by Country/Sub-region, 2022–2032

Table 20: Asia Pacific Market Value (US$ Mn) Forecast, by Product, 2022–2032

Table 21: Asia Pacific Market Value (US$ Mn) Forecast, by Hearing Aids, 2022–2032

Table 22: Asia Pacific Market Value (US$ Mn) Forecast, by Diagnostic Devices, 2022–2032

Table 23: Asia Pacific Market Value (US$ Mn) Forecast, by Disease, 2022–2032

Table 24: Asia Pacific Market Value (US$ Mn) Forecast, by End-user, 2022–2032

Table 25: Latin America Market Value (US$ Mn) Forecast, by Country/Sub-region, 2022–2032

Table 26: Latin America Market Value (US$ Mn) Forecast, by Product, 2022–2032

Table 27: Latin America Market Value (US$ Mn) Forecast, by Hearing Aids, 2022–2032

Table 28: Latin America Market Value (US$ Mn) Forecast, by Diagnostic Devices, 2022–2032

Table 29: Latin America Market Value (US$ Mn) Forecast, by Disease, 2022- 2032

Table 30: Latin America Market Value (US$ Mn) Forecast, by End-user, 2022–2032

Table 31: Middle East & Africa Market Value (US$ Mn) Forecast, by Country/Sub-region, 2022–2032

Table 32: Middle East & Africa Market Value (US$ Mn) Forecast, by Product, 2022-2032

Table 33: Middle East & Africa Market Value (US$ Mn) Forecast, by Hearing Aids, 2022–2032

Table 34: Middle East & Africa Market Value (US$ Mn) Forecast, by Diagnostic Devices, 2022–2032

Table 35: Middle East & Africa Market Value (US$ Mn) Forecast, by Disease, 2022–2032

Table 36: Middle East & Africa Market Value (US$ Mn) Forecast, by End-user, 2022–2032

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

List Of Figures

Figure 01: Global Market Size (US$ Mn) and Distribution, by Region, 2022 and 2032

Figure 02: Global Market Revenue (US$ Mn), by Product, 2022

Figure 03: Global Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022–2032

Figure 04: Global Market Value (US$ Mn) Forecast, 2022–2032

Figure 05: Global Market Value Share (%), by Product, 2022 and 2032

Figure 06: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hearing Aids, 2022–2032

Figure 07: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Cochlear Implants, 2022–2032

Figure 08: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Bone-anchored Hearing Aids, 2022–2032

Figure 09: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Diagnostic Devices, 2022–2032

Figure 10: Global Market Attractiveness Analysis, by Product, 2022–2032

Figure 11: Global Market Value Share (%), by Disease, 2022 and 2032

Figure 12: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Otosclerosis, 2022–2032

Figure 13: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Meniere's Disease, 2022–2032

Figure 14: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Acoustic Tumors, 2022–2032

Figure 15: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Otitis Media, 2022–2032

Figure 16: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2022–2032

Figure 17: Global Market Attractiveness Analysis, by Disease, 2022–2032

Figure 18: Global Market Value Share, by End-user, 2022 and 2032

Figure 19: Global Market Attractiveness, by End-user, 2022–2032

Figure 20: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospitals, 2022–2032

Figure 21: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Ambulatory Surgical Centers, 2022–2032

Figure 22: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Clinics, 2022–2032

Figure 23: Global Market Value Share, by Region, 2022 and 2032

Figure 24: Global Market Attractiveness, by Region, 2022–2032

Figure 25: North America Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2022–2032

Figure 26: North America Market Value Share (%), by Country, 2022 and 2032

Figure 27: North America Market Attractiveness, by Country, 2022–2032

Figure 28: North America Market Value Share, by Product, 2022 and 2032

Figure 29: North America Market Attractiveness, by Product, 2022–2032

Figure 30: North America Market Value Share Analysis, by Disease, 2022 and 2032

Figure 31: North America Market Attractiveness, by Disease, 2022–2032

Figure 32: North America Market Value Share Analysis, by End-user, 2022 and 2032

Figure 33: North America Market Attractiveness, by End-user, 2022–2032

Figure 34: Europe Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2022–2032

Figure 35: Europe Market Value Share (%), by Country/Sub-region, 2022 and 2032

Figure 36: Europe Market Attractiveness, by Country/Sub-region, 2022–2032

Figure 37: Europe Market Value Share, by Product, 2022 and 2032

Figure 38: Europe Market Attractiveness, by Product, 2022–2032

Figure 39: Europe Market Value Share Analysis, by Disease, 2022 and 2032

Figure 40: Europe Market Attractiveness, by Disease, 2022–2032

Figure 41: Europe Market Value Share Analysis, by End-user, 2022 and 2032

Figure 42: Europe Market Attractiveness, by End-user, 2022–2032

Figure 43: Asia Pacific Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2022–2032

Figure 44: Asia Pacific Market Value Share, by Country/Sub-region, 2022 and 2032

Figure 45: Asia Pacific Market Attractiveness, by Country/Sub-region, 2022–2032

Figure 46: Asia Pacific Market Value Share, by Product, 2022 and 2032

Figure 47: Asia Pacific Market Attractiveness, by Product, 2022–2032

Figure 48: Asia Pacific Market Value Share Analysis, by Disease, 2022 and 2032

Figure 49: Asia Pacific Market Attractiveness, by Disease, 2022–2032

Figure 50: Asia Pacific Market Value Share Analysis, by End-user, 2022 and 2032

Figure 51: Asia Pacific Market Attractiveness, by End-user, 2022–2032

Figure 52: Latin America Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2022–2032

Figure 53: Latin America Market Value Share, by Country/Sub-region, 2022 and 2032

Figure 54: Latin America Market Attractiveness, by Country/Sub-region, 2022–2032

Figure 55: Latin America Market Value Share, by Product, 2022 and 2032

Figure 56: Latin America Market Attractiveness, by Product, 2022–2032

Figure 57: Latin America Market Value Share Analysis, by Disease, 2022 and 2032

Figure 58: Latin America Market Attractiveness, by Disease, 2022–2032

Figure 59: Latin America Market Value Share Analysis, by End-user, 2022 and 2032

Figure 60: Latin America Market Attractiveness, by End-user, 2022–2032

Figure 61: Middle East & Africa Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2022–2032

Figure 62: Middle East & Africa Market Value Share, by Country/Sub-region, 2022 and 2032

Figure 63: Middle East & Africa Market Attractiveness, by Country/Sub-region, 2022–2032

Figure 64: Middle East & Africa Market Value Share, by Product, 2022 and 2032

Figure 65: Middle East & Africa Market Attractiveness, by Product, 2022–2032

Figure 66: Middle East & Africa Market Value Share Analysis, by Disease, 2022 and 2032

Figure 67: Middle East & Africa Market Attractiveness, by Disease, 2022–2032

Figure 68: Middle East & Africa Market Value Share Analysis, by End-user, 2022 and 2032

Figure 69: Middle East & Africa Market Attractiveness, by End-user, 2022–2032

Figure 70: William Demant Holding A/S Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2021

Figure 71: William Demant Holding A/S Breakdown of Net Sales (%), by Region/Country, 2022

Figure 72: William Demant Holding A/S Breakdown of Net Sales (%), by Product Segment, 2022

Figure 73: William Demant Holding A/S R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2021

Figure 74: GN Store Nord A/S Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2021

Figure 75: GN Store Nord A/S Breakdown of Net Sales (%), by Product Segment, 2022

Figure 76: GN Store Nord A/S Breakdown of Net Sales (%) of GN Hearing Segment, by Region/Country, 2022

Figure 77: Sonova Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2021

Figure 78: Sonova Breakdown of Net Sales (%), by Region/Country, 2022

Figure 79: Sonova Breakdown of Net Sales (%), by Product Segment, 2022

Figure 80: Sonova R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2022–2032

Figure 81: WIDEX A/S Revenue (US$ Mn) and Y-o-Y Growth (%), 2016/17–2017/22

Figure 82: WIDEX A/S Breakdown of Net Sales (%), by Region/Country, 2017/22

Figure 83: Sonova Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2021

Figure 84: Medtronic Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2021

Figure 85: Medtronic Breakdown of Net Sales (%), by Region/Country/geography, 2022

Figure 86: Medtronic Breakdown of Net Sales (%), by Business Segment, 2022

Figure 87: Medtronic R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2021

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

- FAQs -

At what value will the Audiological Devices market close in 2022?

As of 2022, Fact.MR expects the Audiological Devices industry to be valued at US$ 10.81 Billion.

At what percentage will the industry expand during the 2022-2032 period of assessment?

From 2022 to 2032, the Audiological Devices industry is poised to flourish at a 5.3% CAGR.

What is the expected closing market value for Audiological Devices in 2032?

By 2032, the Audiological Devices landscape is slated to reach a valuation of US$ 18.13 Billion.

By Product, which segment is likely to experience the fastest growth rate?

Hearing Aids Segment is expected to grow the fastest, at a CAGR of 5.2%.

Which is the most preferred disease type category of Audiological Devices?

By Disease Type, the Meniere’s Disease segment is expected to dominate the market, documenting a 5.1% value CAGR.

How will the North American market for Audiological Devices flourish until 2032?

As per Fact.MR’s projections, the market for Audiological Devices in North America will likely expand at a 5.2% CAGR.

What will be the growth scenario for the market in Asia Pacific until 2032?

Asia Pacific is poised to yield a CAGR of 5.1% with respect to Audiological Devices in 2032.

What was the market worth for Audiological Devices in 2021?

As of 2021, the Audiological Devices market was valued at US$ 10.27 Billion.

From 2017-2021, what was the documented growth rate for the Audiological Devices market?

According to Fact.MR, a CAGR of 2.4% was recorded for the Audiological Devices market from 2017-2021.

Audiological Devices Market

Schedule a Call